ProQR Therapeutics (PRQR) Return on Sales [ROS] (2021 - 2026)
ProQR Therapeutics (PRQR) posted Return on Sales [ROS] of -100.72% for the quarter ended Jun 30, 2026, up 220.19 percentage points from -320.91% a year earlier and up 570.65 percentage points from the prior quarter.
ProQR Therapeutics (PRQR) Return on Sales [ROS] (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at ProQR Therapeutics was -233.85%, up 20.87 percentage points year-over-year; for the year ended Dec 31, 2025, it was -273.14%, down 111.96 percentage points from the prior year.
- Annual Return on Sales [ROS] shows a four-year change of +4012.25 percentage points (years ended Dec 2021 to Dec 2025).
- In prior years, ProQR Therapeutics' Return on Sales [ROS] was -161.18% in the year ended Dec 31, 2024 (+327.90 pp), -489.09% in the year ended Dec 31, 2023 (+1323.91 pp), -1812.99% in the year ended Dec 31, 2022 (+2472.40 pp) and -4285.39% in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Return on Sales [ROS] since the quarter ended Jun 30, 2024.
- On a year-over-year basis, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of -48.60 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was the quarter ended Dec 31, 2022, with a gain of 5519.65 percentage points; the weakest was the quarter ended Sep 30, 2022, with a drop of 765.88 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -671.37% (quarter ended Mar 31, 2026), -194.05% (quarter ended Dec 31, 2025) and -391.53% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | ProQR Therapeutics | 171.74 Mn | -291.86 Mn | - | -100.72% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -100.72% |
| Mar 31, 2026 | -671.37% |
| Dec 31, 2025 | -194.05% |
| Sep 30, 2025 | -391.53% |
| Jun 30, 2025 | -320.91% |
| Mar 31, 2025 | -239.34% |
| Dec 31, 2024 | -234.06% |
| Sep 30, 2024 | -226.80% |
| Jun 30, 2024 | -57.10% |
| Mar 31, 2024 | -181.46% |
| Dec 31, 2023 | -190.86% |
| Sep 30, 2023 | -539.49% |
| Jun 30, 2023 | -731.20% |
| Mar 31, 2023 | -1,433.44% |
| Dec 31, 2022 | -1,730.56% |
| Sep 30, 2022 | -2,435.26% |
| Jun 30, 2022 | -1,702.37% |
| Mar 31, 2022 | -1,508.32% |
| Dec 31, 2021 | -7,250.21% |
| Sep 30, 2021 | -1,669.38% |
ProQR Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();